99
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A Practical Nomogram for Predicting the Prognosis of Elderly Patients with Gastric Adenocarcinoma After Gastrectomy

, , ORCID Icon, , , , & show all
Pages 473-488 | Published online: 11 Jan 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Yang L, Ying X, Liu S, et al. Gastric cancer: epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32(6):695–704. doi:10.21147/j.issn.1000-9604.2020.06.03
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
  • Yan S, Gan Y, Song X, et al. Association between refrigerator use and the risk of gastric cancer: a systematic review and meta-analysis of observational studies. PLoS One. 2018;13(8):e0203120. doi:10.1371/journal.pone.0203120
  • Zhang T, Chen H, Yin X, et al. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: findings from Global Burden of Disease Study. Chin J Cancer Res. 2021;33(1):11–26. doi:10.21147/j.issn.1000-9604.2021.01.02
  • Song P, Wu L, Jiang B, Liu Z, Cao K, Guan W. Age-specific effects on the prognosis after surgery for gastric cancer: a SEER population-based analysis. Oncotarget. 2016;7(30):48614–48624. doi:10.18632/oncotarget.9548
  • Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–648. doi:10.1016/S0140-6736(20)31288-5
  • Biondi A, Cananzi FC, Persiani R, et al. The road to curative surgery in gastric cancer treatment: a different path in the elderly. J Am Coll Surg. 2012;215(6):858–867. doi:10.1016/j.jamcollsurg.2012.08.021
  • Takeshita H, Ichikawa D, Komatsu S, et al. Surgical outcomes of gastrectomy for elderly patients with gastric cancer. World J Surg. 2013;37(12):2891–2898. doi:10.1007/s00268-013-2210-7
  • Wang X, Zhao J, Fairweather M, Yang T, Sun Y, Wang J. Optimal treatment for elderly patients with resectable proximal gastric carcinoma: a real world study based on National Cancer Database. BMC Cancer. 2019;19(1):1079. doi:10.1186/s12885-019-6166-3
  • Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–180. doi:10.1016/S1470-2045(14)71116-7
  • National Cancer Institute [homepage on the Internet]. Surveillance, epidemiology, and end results. Available from: http://www.seer.cancer.gov. Accessed December 29, 2021.
  • Crews DE, Zavotka S. Aging, disability, and frailty: implications for universal design. J Physiol Anthropol. 2006;25(1):113–118. doi:10.2114/jpa2.25.113
  • Frank EHJ. [homepage on the Internet]. Rms: Regression Modeling Strategies. R Package version 3.4-4. Available from: http://www.rproject.org/. Accessed December 29, 2021.
  • Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801. doi:10.1016/S1470-2045(12)70211-5
  • Egner JR. AJCC cancer staging manual. JAMA. 2010;304(15):1726–1727. doi:10.1001/jama.2010.1525
  • Kattan MW, Hess KR, Amin MB, et al. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016;66(5):370–374. doi:10.3322/caac.21339
  • Alshehri A, Alanezi H, Kim BS. Prognosis factors of advanced gastric cancer according to sex and age. World J Clin Cases. 2020;8(9):1608–1619. doi:10.12998/wjcc.v8.i9.1608
  • Nelen SD, Bosscha K, Lemmens V, Hartgrink HH, Verhoeven R, de Wilt J. Morbidity and mortality according to age following gastrectomy for gastric cancer. Br J Surg. 2018;105(9):1163–1170. doi:10.1002/bjs.10836
  • Hashimoto T, Kurokawa Y, Mikami J, et al. Postoperative long-term outcomes in elderly patients with gastric cancer and risk factors for death from other diseases. World J Surg. 2019;43(11):2885–2893. doi:10.1007/s00268-019-05109-5
  • Tee MC, Pirozzi N, Brahmbhatt RD, Raman S, Franko J. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States. Eur J Surg Oncol. 2020;46(10Pt A):1941–1947. doi:10.1016/j.ejso.2020.05.014
  • Jin H, Pinheiro PS, Callahan KE, Altekruse SF. Examining the gastric cancer survival gap between Asians and whites in the United States. Gastric Cancer. 2017;20(4):573–582. doi:10.1007/s10120-016-0667-4
  • Zhou L, Li W, Cai S, Yang C, Liu Y, Lin Z. Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell: results from the surveillance, epidemiology, and end results database. Medicine (Baltimore). 2019;98(40):e17367. doi:10.1097/MD.0000000000017367
  • Liang Y, Liu L, Xie X, et al. Tumor size improves the accuracy of the prognostic prediction of lymph node-negative gastric cancer. J Surg Res. 2019;240:89–96. doi:10.1016/j.jss.2019.02.037
  • Xue J, Yang H, Huang S, Zhou T, Zhang X, Zu G. Comparison of the overall survival of proximal and distal gastric cancer after gastrectomy: a systematic review and meta-analysis. World J Surg Oncol. 2021;19(1):17. doi:10.1186/s12957-021-02126-4
  • Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564–1571. doi:10.1136/gutjnl-2020-321600
  • Duan Q, Tang C, Ma Z, et al. Genomic heterogeneity and clonal evolution in gastroesophageal junction cancer revealed by single cell DNA sequencing. Front Oncol. 2021;11:672020. doi:10.3389/fonc.2021.672020
  • Yang H, Li X, Shi J, et al. A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer. Cancer Manag Res. 2018;10:6611–6626. doi:10.2147/CMAR.S182458
  • Wu SC, Chiang MC, Lee YG, et al. Long-term survival and prognostic implications of patients with invasive breast cancer in southern Taiwan. Medicine (Baltimore). 2020;99(7):e19122. doi:10.1097/MD.0000000000019122
  • Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EH. Cancer of the esophagus and esophagogastric junction-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):304–317. doi:10.3322/caac.21399
  • Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–730. doi:10.1056/NEJMoa010187
  • Fuchs CS, Niedzwiecki D, Mamon HJ, et al. Adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: results from CALGB 80101 (Alliance). J Clin Oncol. 2017;35(32):3671–3677. doi:10.1200/JCO.2017.74.2130
  • Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20. doi:10.1056/NEJMoa055531
  • Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, Phase 2/3 trial. Lancet. 2019;393(10184):1948–1957. doi:10.1016/S0140-6736(18)32557-1
  • Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized Phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–4393. doi:10.1200/JCO.2011.36.5908
  • Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a Phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–321. doi:10.1016/S0140-6736(11)61873-4
  • Zhang J, Gan L, Wu Z, Yan S, Liu X, Guo W. The influence of marital status on the stage at diagnosis, treatment, and survival of adult patients with gastric cancer: a population-based study. Oncotarget. 2017;8(14):22385–22405. doi:10.18632/oncotarget.7399
  • Wu Y, Ai Z, Xu G. Marital status and survival in patients with non-small cell lung cancer: an analysis of 70006 patients in the SEER database. Oncotarget. 2017;8(61):103518–103534. doi:10.18632/oncotarget.21568
  • Liu YL, Wang DW, Yang ZC, et al. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database. Breast Cancer Res Treat. 2019;178(2):379–388. doi:10.1007/s10549-019-05385-8
  • Alyabsi M, Ramadan M, Algarni M, Alshammari K, Jazieh AR. The effect of marital status on stage at diagnosis and survival in Saudis diagnosed with colorectal cancer: cancer registry analysis. Sci Rep. 2021;11(1):8603. doi:10.1038/s41598-021-88042-9